title: The role of liver iron in hepatitis C antiviral treatment.
authors.forename: Khaled M
authors.initials: KM
authors.lastname: Musallam
authors.forename: Ala I
authors.initials: AI
authors.lastname: Sharara
authors.forename: Adlete
authors.initials: A
authors.lastname: Inati
authors.forename: Ali T
authors.initials: AT
authors.lastname: Taher
mesh_terms: D000755:Anemia, Sickle Cell / Q000150:complications* / Q000628:therapy; D000998:Antiviral Agents / Q000627:therapeutic use*; D001803:Blood Transfusion; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D007501:Iron / Q000032:analysis / Q000378:metabolism*; D008099:Liver / Q000378:metabolism*; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*; D017086:beta-Thalassemia / Q000150:complications* / Q000628:therapy
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; D007501:Iron; C100416:peginterferon alfa-2a